Skip to main content

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA

Position in NVO — Novo Nordisk A S

CIK 932974 BOSTON, MA

Position in NVO

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$1,735,044
-$2,144,065 QoQ
Shares Held
36,192
-65.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#407
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $220,949,345 across 14 Drug Manufacturers - General names. NVO ranks #7 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
36,192 $1,735,044

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,735,044 36,192
2026-03-31 $3,879,109 105,554
2025-12-31 $5,464,410 107,398
2025-09-30 $6,216,045 112,021
2025-06-30 $8,160,924 118,240
2025-03-31 $8,404,323 121,030
2024-12-31 $9,779,441 113,688
2024-09-30 $3,825,838 32,131
2024-06-30 $4,682,585 32,805
2024-03-31 $2,606,648 20,301
2023-12-31 $2,114,104 20,436
2023-09-30 $1,858,449 20,436
2023-06-30 $1,666,525 10,298
2023-03-31 $1,638,823 10,298
2022-12-31 $1,481,837 10,949
2022-09-30 $1,090,848 10,949
2022-06-30 $1,220,047 10,949
2022-03-31 $1,215,886 10,949
2021-12-31 $1,226,288 10,949
2021-09-30 $1,066,575 11,109
2021-06-30 $1,007,669 12,029
2021-03-31 $819,018 12,148
2020-12-31 $850,423 12,175
2020-09-30 $826,217 11,900
2020-06-30 $779,212 11,900
2020-03-31 $686,280 11,400